These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8454353)

  • 1. Complete development of Cryptosporidium parvum in a human endometrial carcinoma cell line.
    Rasmussen KR; Larsen NC; Healey MC
    Infect Immun; 1993 Apr; 61(4):1482-5. PubMed ID: 8454353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete development of Cryptosporidium parvum in MDBK cells.
    Villacorta I; de Graaf D; Charlier G; Peeters JE
    FEMS Microbiol Lett; 1996 Aug; 142(1):129-32. PubMed ID: 8759799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual and asexual development of Cryptosporidium parvum in five oocyst- or sporozoite-infected human enterocytic cell lines.
    Maillot C; Favennec L; Francois A; Ducrotte P; Brasseur P
    J Eukaryot Microbiol; 1997; 44(6):582-5. PubMed ID: 9435129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism.
    Chen XM; Levine SA; Tietz P; Krueger E; McNiven MA; Jefferson DM; Mahle M; LaRusso NF
    Hepatology; 1998 Oct; 28(4):906-13. PubMed ID: 9755224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of Cryptosporidium parvum oocysts in natural waters.
    Brasseur P; Uguen C; Moreno-Sabater A; Favennec L; Ballet JJ
    Folia Parasitol (Praha); 1998; 45(2):113-6. PubMed ID: 9684321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro.
    Shahiduzzaman M; Ras R; Widmer G
    Exp Parasitol; 2020 May; 212():107873. PubMed ID: 32165146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry based assay to determine the effects of treatments on Cryptosporidium parvum viability.
    Phelps KK; Lindsay DS; Sumner SS; Fayer R
    J Eukaryot Microbiol; 2001; Suppl():40S-41S. PubMed ID: 11906073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of Cryptosporidium growth in in vitro culture--the impact of parasite density on the success of infection.
    Paziewska-Harris A; Singer M; Schoone G; Schallig H
    Parasitol Res; 2016 Jan; 115(1):329-37. PubMed ID: 26435485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
    Edwards H; Thompson RC; Koh WH; Clode PL
    Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages.
    Mirhashemi ME; Noubary F; Chapman-Bonofiglio S; Tzipori S; Huggins GS; Widmer G
    Parasit Vectors; 2018 Mar; 11(1):176. PubMed ID: 29530089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells.
    Upton SJ; Tilley M; Brillhart DB
    J Clin Microbiol; 1995 Feb; 33(2):371-5. PubMed ID: 7714194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture.
    Gold D; Stein B; Tzipori S
    J Parasitol; 2001 Oct; 87(5):997-1000. PubMed ID: 11695421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa).
    Snelling WJ; Lin Q; Moore JE; Millar BC; Tosini F; Pozio E; Dooley JS; Lowery CJ
    Mol Cell Proteomics; 2007 Feb; 6(2):346-55. PubMed ID: 17124246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological changes and viability of Cryptosporidium parvum sporozoites after excystation in cell-free culture media.
    Matsubayashi M; Ando H; Kimata I; Nakagawa H; Furuya M; Tani H; Sasai K
    Parasitology; 2010 Nov; 137(13):1861-6. PubMed ID: 20800015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).
    Upton SJ; Tilley M; Nesterenko MV; Brillhart DB
    FEMS Microbiol Lett; 1994 May; 118(1-2):45-9. PubMed ID: 8013881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture.
    Hijjawi NS; Meloni BP; Morgan UM; Thompson RC
    Int J Parasitol; 2001 Aug; 31(10):1048-55. PubMed ID: 11429168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells.
    Yang S; Healey MC; Du C; Zhang J
    Infect Immun; 1996 Jan; 64(1):349-54. PubMed ID: 8557363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro cultivation model of Cryptosporidium parvum in MDCK cells and its development].
    Chen F; Huang KH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Jun; 27(3):219-22. PubMed ID: 19852362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.